Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
The Pharmaceutical Market: Latvia
Management Report
Published: January 2010
Pages: 38
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 595.00 Buy Now!
Research from: pharmaceuticalmarketresearch
Sector: Prescription Medicines
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Latvia is one of the smallest countries in Europe. It joined the EU in May 2004 and NATO two months earlier. In 2010, it has an estimated population of 2.2 million with the most populous city being Riga, the capital. As with other European countries, Latvia has an ageing population, with those aged 65 and over representing 18.1% of the population.
Funding for healthcare in Latvia is managed by the State Compulsory Health Insurance Agency, although funds are gathered largely through general taxation. Treatments guaranteed to all Latvians and foreign residents include emergency care, treatment for acute and chronic diseases, maternity care, prevention and treatment of infectious diseases (including tuberculosis and HIV/AIDS), immunisation coverage, oncology, haematology and provision of certain pharmaceuticals to eligible groups.
Around 66% of the pharmaceutical market is supplied by imports. Switzerland, Lithuania and Germany were the leading suppliers in 2008, accounting for over 46% of imports. Imports have generally grown every year since 2001, despite a slight fall in 2007.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care data
Funding for healthcare in Latvia is managed by the State Compulsory Health Insurance Agency, although funds are gathered largely through general taxation. Treatments guaranteed to all Latvians and foreign residents include emergency care, treatment for acute and chronic diseases, maternity care, prevention and treatment of infectious diseases (including tuberculosis and HIV/AIDS), immunisation coverage, oncology, haematology and provision of certain pharmaceuticals to eligible groups.
Around 66% of the pharmaceutical market is supplied by imports. Switzerland, Lithuania and Germany were the leading suppliers in 2008, accounting for over 46% of imports. Imports have generally grown every year since 2001, despite a slight fall in 2007.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care data